Home/Filings/4/0001628280-25-049159
4//SEC Filing

de Verneuil Vanina 4

Accession 0001628280-25-049159

CIK 0001706431other

Filed

Nov 3, 7:00 PM ET

Accepted

Nov 4, 7:40 PM ET

Size

5.0 KB

Accession

0001628280-25-049159

Insider Transaction Report

Form 4
Period: 2025-11-03
de Verneuil Vanina
EVP and General Counsel
Transactions
  • Sale

    Common Stock

    2025-11-03$5.86/sh1,365$8,00380,595 total
Footnotes (2)
  • [F1]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
  • [F2]Includes 2,500 shares of common stock acquired by the Reporting Person on May 30, 2025 pursuant to an employee stock purchase program.

Issuer

Vir Biotechnology, Inc.

CIK 0001706431

Entity typeother

Related Parties

1
  • filerCIK 0002036234

Filing Metadata

Form type
4
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 7:40 PM ET
Size
5.0 KB